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Airway inflammation and remodeling are characteristic features of asthma, both contributing to 37 
airway hyperresponsiveness (AHR) and lung function limitation. Airway smooth muscle (ASM) 38 
accumulation and extracellular matrix deposition are characteristic features of airway remodeling, 39 
which may contribute to persistent AHR. Laminins containing the α2 chain contribute to 40 
characteristics of ASM remodeling in vitro and AHR in animal models of asthma. The role of other 41 
laminin chains, including the laminin α4 and α5 chains, which contribute to leukocyte migration in 42 
other diseases, is currently unknown. The aim of the current study was to investigate the role of 43 
these laminin chains in ASM function and in AHR, remodeling and inflammation in asthma. 44 
Expression of both laminin α4 and α5 was observed in the human and mouse ASM bundle. In vitro, 45 
laminin α4 was found to promote a pro-proliferative, pro-contractile and pro-fibrotic ASM cell 46 
phenotype. In line, treatment with laminin α4 and α5 function-blocking antibodies reduced allergen-47 
induced increases in ASM mass in a mouse model of allergen-induced asthma. Moreover, 48 
eosinophilic inflammation was reduced by the laminin α4 function-blocking antibody as well. Using 49 
airway biopsies from healthy subjects and asthmatic patients, we found inverse correlations 50 
between ASM α4 chain expression and lung function and AHR, whereas eosinophil numbers 51 
correlated positively with expression of laminin α4 in the ASM bundle. This study for the first time 52 
indicates a prominent role for laminin α4 in ASM function and in inflammation, AHR and remodeling 53 
in asthma, whereas the role of laminin α5 is more subtle.   54 




Introduction  55 
Asthma is a chronic airway disease, associated with airway inflammation and structural changes in 56 
the airway architecture, termed ‘remodeling’ (13). Both inflammation and remodeling may lead to 57 
airway hyperresponsiveness (AHR), defined as an exaggerated obstructive response to various non-58 
specific stimuli (29). Airway remodeling includes increased airway smooth muscle (ASM) mass and 59 
contractility, and abnormal extracellular matrix (ECM) turnover resulting in an increased deposition 60 
(13). Studies on ECM modifications in asthma revealed an altered airway presence of several 61 
laminins (1, 2). Laminins are a group of heterotrimeric proteins comprised of five α, three β and 62 
three γ chains (4). Together with collagen IV, nidogens and proteoglycans, laminins constitute the 63 
main functional components of basement membranes (BMs). In the healthy lung, laminin α2, α3, α5, 64 
β1-3, and γ1-2 are localized in the BMs beneath the airway epithelium, while laminin α4, β1-2 and γ1 65 
are present in ASM BMs (1, 8, 22, 25, 28, 42). Studies on the expression of the laminin chains in the 66 
airways of asthmatics are limited and focused on epithelial BMs. In these BMs, laminin α2, α3, α5, 67 
β1-2 and γ1 were found to be increased (1, 2). 68 
Increased ASM mass may be related to switching of the ASM cell between proliferative and 69 
contractile phenotypes (47). Exposure to proliferative stimuli induces a proliferative ASM phenotype, 70 
associated with increased synthetic function and reduced contractility, whereas removal of mitogens 71 
induces a contractile phenotype (47). In addition to their role as physical and mechanical support, 72 
laminins may also affect ASM phenotype switching. In vitro, laminin-111 (composed of laminin α1, 73 
β1 and γ1) inhibits ASM cell proliferation (9, 14, 18). Moreover, prolonged exposure of ASM cells to 74 
insulin and serum deprivation enhances laminin-211 (α2β1γ1) expression, which also inhibits ASM 75 
proliferation (15, 40). In addition, laminin-111 prevents growth factor-induced reductions in ASM 76 
contractile protein expression and contractility, whereas laminin-211 increases contractile protein 77 
expression and contractility (9, 14, 15, 18, 40). Increased laminin-211 expression may also be 78 
important in vivo, as allergen-induced AHR was not observed in laminin α2-deficient mice (41). 79 




Collectively, these findings suggest that laminins may importantly contribute to airway remodeling 80 
and AHR. However, the role of other laminin chains remains to be explored. 81 
Airway inflammation closely relates to the development of variable and persistent AHR and is 82 
considered to contribute to the development, progression and maintenance of asthma (24). 83 
Laminins are important regulators of immune cell migration (32). Laminin α4 promotes trans-84 
endothelial migration of leukocytes, whereas laminin α5 restricts migration. Extravasation of 85 
leukocytes from blood vessels, in particular T-lymphocytes, but also monocytes and neutrophils, 86 
occurs predominantly at sites of low or absent laminin α5 expression (20, 33, 49).  87 
The role of laminin α4 and α5 in abnormal ASM function in asthma has not been investigated yet. 88 
Therefore, the aim of the current study was to investigate the expression of laminin α4 and α5 in the 89 
airways and their role in airway smooth muscle function and airway remodeling and inflammation in 90 
asthma.   91 




Materials and methods 92 
 93 
Additional detail is provided in the online data supplement 94 
(https://figshare.com/s/e1f9577c4c54ed74fa04). 95 
 96 
Human subjects and bronchial biopsies 97 
Airway wall biopsies from healthy subjects and patients with current asthma were obtained from 98 
two studies (5, 16, 35). Clinical and (immuno)histochemical parameters of the subjects in these 99 
studies have been reported (5, 16, 35). All subjects gave written informed consent. Studies were 100 
approved by the medical ethics committee of the University Medical Center Groningen. Biopsies 101 
used in the current study were selected on the presence of ASM, sections without ASM were 102 
excluded. Corresponding clinical characteristics are outlined in Table 1. 103 
 104 
Immunohistochemistry human biopsies 105 
Bronchial biopsies were cut into 3-μm thick sections. Biopsy sections were stained with laminin α4 106 
and α5 antibodies, horse radish peroxidase-labeled secondary antibodies and diaminobenzidine, 107 
followed by a hematoxylin counterstain. Staining intensity was scored in triplicate by two 108 
independent observers in a blinded manner with scores ranging from 1-4 (Figure S1). The ASM, 109 
epithelium and endothelium were scored individually.  110 
 111 
Transplantation tissue and immunostaining  112 
Human tracheal sections from lung transplantation donors were used in this study (12). Tissue was 113 
collected according to the Research Code of the University Medical Center Groningen and national 114 
ethical and professional guidelines. Cryostat sections (4 µm) were probed with pan-laminin, laminin 115 
α4 or laminin α5 antibodies. Antibodies were a gift from dr. LM Sorokin of the University of 116 
Muenster, Germany. Antibodies were visualized by Alexa-488- or Cy3-labelled secondary antibodies. 117 




Nuclei were labeled with Hoechst-33342. Sections were analyzed using an Olympus AX70 118 
microscope and digital image capture system. 119 
 120 
Cell culture and lentiviral shRNA transduction 121 
Two human bronchial smooth muscle cell lines were used, immortalized by stable expression of 122 
human telomerase reverse transcriptase (17). Cells were used up to passage 30. Cells were 123 
transduced with 3x104 infectious units lentiviral shRNA particles per well (2 ml) to knockdown 124 
laminin α4 (sc-43147-V) or laminin α5 (sc-43149-V) or with scrambled (control) shRNA lentiviral 125 
particles (sc-108080), according to the manufacturer’s instructions. Preliminary results indicated this 126 
concentration of lentiviral particles to be maximally effective in reducing mRNA expression (data not 127 
shown). Stable clones were selected by growing transfected cells in medium containing puromycin. 128 
 129 
Real-time quantitative RT-PCR 130 
Real-time quantitative RT-PCR was performed using standard techniques. These data were analyzed 131 
using the comparative cycle threshold (CT) method. The amount of target gene was normalized to 132 
GAPDH. The specific primers used are listed in Supplemental Table S1. 133 
 134 
Cell proliferation assays  135 
Cell number was determined using both the AlamarBlue conversion assay and cell counting, using a 136 
hemocytometer (12). DNA synthesis was determined using the [3H]-thymidine incorporation assay 137 
(12).  138 
 139 
Animal provocations 140 
Inbred female BALB/c mice were obtained from Charles River. All animal care and experimental 141 
procedures complied with the animal protection and welfare guidelines, were approved by the 142 
Institutional Animal Care and Use Committee of the University of Groningen, The Netherlands. 143 




Animal provocations were performed in two separate protocols, an acute protocol and a chronic 144 
protocol (Figure 3A). For both protocols, animals were sensitized on days 1, 14 and 21 by an 145 
intraperitoneal injection of ovalbumin (OVA) together with aluminum hydroxide in saline (7, 36). 146 
Animals were exposed to aerosolized 1% OVA or saline for 20 min, on day 28-30 (acute protocol) or 147 
days 26, 27, 33, 34, 40, 41, 47 and 48 (chronic protocol). In the acute protocol, animals were 148 
exposed to 5% OVA or saline on day 32 (7). To block laminin α4 and α5 function, 100 μg of anti-149 
laminin α4 or anti-laminin α5 IgG antibodies, respectively or control IgG antibodies were 150 
administered intravenously 1 day prior to the first aerosolized OVA exposure (45). In the chronic 151 
protocol, administration was repeated on day 39. Animals were sacrificed and lungs were harvested 152 
6 hours (acute protocol) or 24 hours (chronic protocol) after the last OVA exposure. Time points 153 
were chosen so as to reflect maximum infiltration of eosinophils after allergen exposure (acute 154 
protocol) or to reflect remodeling and chronic inflammation (chronic protocol)(7, 21). ASM was 155 
visualized by sm-α-actin staining. Eosinophils were visualized by staining for cyanide resistant 156 
endogenous peroxidase activity. Airways within sections were digitally photographed and sm-α-actin 157 
staining and eosinophil numbers were quantified using Image J.  158 
 159 
Statistics 160 
Animal and cell data represents means±SEM. For human experiments, data are presented as 161 
medians. Comparisons between two groups were made using Student's unpaired t-test (normally 162 
distributed data) or a Mann–Whitney U-test (non-parametric equivalent). Comparisons between 163 
three or more groups were performed using a one-way ANOVA, followed by Tukey's post-hoc test 164 
(normally distributed data) or Kruskal–Wallis H-test followed by Dunn’s post-hoc test (non-normally 165 
distributed data). Correlations were calculated by non-parametric Spearman correlations. A value 166 
of P<0.05 was considered statistically significant. Analyses were performed with GraphPad Prism. 167 




Results  168 
 169 
Expression of laminin α4 and α5 in human tissue 170 
To investigate the expression of laminin α4 and α5 in human airways, tracheal sections from lung 171 
transplant donors were stained with immunofluorescent antibodies. Staining with a pan-laminin 172 
antibody showed laminins to be present in the BMs of the epithelium, endothelium, airway and 173 
vascular smooth muscle, and submucosal glands (Figure 1). Laminin α4 was observed in the BMs of 174 
the airway and vascular smooth muscle and endothelium, but not the epithelium. Laminin α5 was 175 
observed in the BMs of the airway and vascular smooth muscle, epithelium, endothelium and 176 
submucosal glands.  177 
 178 
Regulation of human ASM cell phenotype by laminin α4 and α5  179 
Given the important role of the ASM in AHR (13), we subsequently investigated the role of laminin 180 
α4 and α5 in ASM cell function. Laminin α4 mRNA is abundantly expressed by human ASM cells 181 
(ΔCT=12.1±1.0; Figure 2A), which is even higher than the abundantly expressed laminin α2 182 
(ΔCT=13.4±1.1) (40). Laminin α5 mRNA was expressed much lower (ΔCT=17.5±0.6). Lentiviral knock-183 
down of laminin α4 and laminin α5 significantly reduced expression of the respective laminin chains 184 
(Figure 2B-C). In addition, laminin α4 knock-down increased laminin α5 mRNA expression. No 185 
significant effects were observed on other laminin α chains (Supplemental Figure S2). Laminin α4 186 
knock-down significantly reduced baseline ASM cell proliferation, as indicated by cell number (Figure 187 
2D), DNA synthesis and metabolic activity (Supplemental Figure S3). Silencing of laminin α4 reduced 188 
sm-α-actin and fibronectin mRNA expression, while no significant effects were observed on smooth 189 
muscle-myosin heavy chain (sm-MHC) and calponin expression (Figure 2E). Protein expression of sm-190 
α-actin, calponin and fibronectin was also reduced in α4 deficient cells (Figure 2F-H). Silencing of 191 
laminin α5 significantly increased sm-MHC and calponin mRNA expression, however, this increase is 192 




not carried through to the protein level. Collectively, these data indicate that laminin α4 may play an 193 
important role in triggering a pro-fibrotic, pro-proliferative, and pro-contractile ASM phenotype.  194 
 195 
Laminin α4 and α5 regulate ASM remodeling in vivo. 196 
To explore the potential role of laminin α4 and α5 in ASM remodeling in vivo, we evaluated the 197 
effects of function-blocking antibodies in a mouse model of chronic allergic asthma (Figure 3A). This 198 
model is characterized by an allergen-induced inflammatory response, AHR and airway remodeling, 199 
including increased ASM mass (23). In this model, similar localization profiles were observed for 200 
laminin α4 and α5 in lung cryo-sections as for human tissue (Figure 3B). To investigate the role of 201 
both laminin chains in ASM remodeling, mice were treated with laminin α4 or α5 function-blocking 202 
antibodies. Allergen-induced ASM accumulation induced by repeated allergen challenge, as 203 
observed in control IgG-treated animals, was completely prevented by both laminin blocking-204 
antibodies (Figure 3C). No effects were observed in saline-challenged animals. In addition, no effects 205 
were observed on ASM mass in the acute model (Figure S4). Collectively, these observations indicate 206 
that both laminin α4 and α5 are involved in allergen-induced ASM accumulation induced by 207 
repeated allergen challenge. 208 
 209 
Laminin α4 regulates eosinophil infiltration. 210 
Airway inflammation, particularly influx of eosinophilic granulocytes, closely relates to AHR in allergic 211 
asthma (24). As laminin α4 and α5 have been shown to be important in leukocyte migration (32), we 212 
next investigated their potential role in eosinophil infiltration in an acute and chronic challenge 213 
protocol (Figure 3A). In the acute model, the laminin α4 function-blocking antibody significantly 214 
reduced both basal and allergen-induced increase in airway eosinophils (Figure 4A), whereas the 215 
laminin α5 function-blocking antibody tended to decrease airway eosinophils (P=0.07). In the chronic 216 
model, treatment with the α4 antibody significantly reduced allergen-induced airway eosinophilia 217 
(Figure 4B). As in the acute model, no significant effect of the α5 antibody was observed. No effects 218 




were observed in saline-challenged animals. In both models, no significant effect of the antibodies 219 
on eosinophils surrounding the vasculature was observed either (data not shown). Collectively, these 220 
findings indicate that in addition to its role in ASM remodeling, laminin α4 also contributes to 221 
leukocyte infiltration in a mouse model of asthma. 222 
 223 
ASM laminin α4 is associated with lung function, AHR and eosinophilia in asthma  224 
To investigate the potential role of laminin α4 and α5 expression in patients, staining intensity was 225 
scored in biopsies of healthy subjects and asthmatic patients (Figure S1). Staining patterns in airway 226 
biopsies (Figure 5A en 5B) were similar to those observed in tracheal sections (Figure 1). A small, but 227 
significant increase in endothelial laminin α4 expression was observed in asthmatic patients 228 
compared to healthy controls (Supplemental Table S2). Surprisingly, a significant reduction in ASM 229 
laminin α4 and laminin α5 expression was observed in asthmatic patients. For laminin α4, this 230 
reduction appeared to be due to an interaction between smoking and asthma, as laminin α4 231 
expression was only significantly reduced in smoking asthmatics (Supplemental Figure S5). For 232 
laminin α5, the reduction observed in asthmatic patients was independent of smoking. No 233 
differences were observed in endothelial or epithelial laminin α5 expression (Supplemental Table 234 
S2).  235 
To investigate associations of laminin expression with clinical and biochemical parameters, 236 
expression was associated with previously published patient characteristics (5). Scores were grouped 237 
into low (score 1-2) and high (score 3-4). Interestingly, increased ASM laminin α4 staining in the 238 
asthmatic patients was associated with reduced lung function (lower FEV1 and lower FEV1/FVC) 239 
(Figure 5C-D), increased airway reactivity to adenosine monophosphate (AMP) (Figure 5E) and 240 
increased eosinophil numbers (Figure 5F). Similar associations were observed when smoking 241 
subjects were excluded from the analysis. Associations per individual staining score (1-4) are 242 
available in Supplemental Figure S6. No associations were observed for endothelial laminin α4 243 
staining (Supplemental Figure S7) or ASM laminin α5 staining (data not shown). Higher endothelial 244 




laminin α5 staining was associated with increased numbers of macrophages and reduced neutrophil 245 
numbers (P<0.05, both; Supplemental Figure S8). No associations were observed with other 246 
parameters.  247 
Previously, T-lymphocyte migration has been shown to be dependent on the laminin α4/α5 248 
ratio (49). In line with these observations, a laminin α4/α5 ratio of >1 was associated with reduced 249 
lung function, increased AMP responsiveness and increased eosinophil numbers in asthma patients 250 
(Figure S9).   251 





In the current study, we demonstrate for the first time that laminin α4 may contribute importantly 253 
to the abnormal ASM function in asthma. In vitro, high expression of laminin α4 by ASM cells was 254 
found and knock-down of this laminin reduced proliferation, contractile protein expression and ECM 255 
production, processes which are involved in airway remodeling, AHR and lung function decline in 256 
asthma. Accordingly, in asthmatic patients, ASM laminin α4 expression was correlated with AHR, 257 
reduced lung function and increased eosinophil numbers and in an animal model in vivo, laminin α4-258 
blocking antibodies reduced allergen-induced ASM remodeling and inflammation. Although no 259 
obvious effects were observed for laminin α5 silencing in vitro, in vivo blockade of laminin α5 260 
prevented allergen-induced ASM increases.  261 
Airway remodeling is a characteristic feature of chronic asthma and contributes to persistent 262 
AHR. Increased ECM deposition is an important characteristic of airway remodeling (13). Various 263 
ECM proteins, including collagens and fibronectin, are increased in the epithelial BM of asthmatic 264 
patients (6, 31). In addition, increased expression of several laminins, including laminin α5, have 265 
been reported (1, 2). In the current study no increase in epithelial laminin α5 expression was 266 
observed. This may be explained by the parameter analyzed. In the current study, laminin staining 267 
intensity was scored, whereas in the previous study the thickness of the stained BMs was quantified 268 
(2). In the present study, intensity scoring was chosen as this method can also be used for other 269 
compartments, including the ASM. Increased ECM presence, including fibronectin and elastin, has 270 
also been shown in the ASM of asthmatic patients, which is related to airway function (3, 34). 271 
Another study showed no differences in the fractional area of ECM components in the ASM of 272 
asthmatic subjects (51). In that study, however, an inverse correlation was found between the 273 
fractional area of (pan-)laminin in the ASM bundle and FEV1 reversibility (51). Remarkably, we show 274 
that both laminin α4 and α5 staining is reduced in the ASM of asthmatics. However, although 275 
laminin α4 expression was reduced, there were significant associations between ASM laminin α4 276 
expression and lung function and AHR within the group of asthmatic patients. This paradoxical 277 




observation might be related to an interaction between asthma and smoking. The mechanisms 278 
behind this interaction, however, are currently unknown and warrant further investigation. 279 
The association between laminin α4 and lung function and AHR could be related to laminin 280 
α4-induced ASM cell phenotype changes. In vitro laminin α4 knock-down reduced ASM cell 281 
proliferation, contractile protein expression and fibronectin expression. These findings are in line 282 
with observations showing that ECM proteins are important regulators of ASM phenotype switching. 283 
Monomeric collagen I and fibronectin induce a proliferative phenotype, whereas laminin-111 and 284 
laminin-211 inhibit phenotype switching (9, 12, 14, 15, 18, 26). In vivo, treatment with a laminin α4-285 
blocking antibody prevented allergen-induced ASM increase in a mouse model of asthma, 286 
supporting a role for laminin α4 in ASM abnormalities in asthma. The reduction in ASM mass may, 287 
however, also be (partly) indirect due to inhibition of eosinophil infiltration. Surprisingly, although 288 
only limited effects were observed for laminin α5 in vitro, in vivo blockade of this laminin fully 289 
prevented allergen-induced ASM accumulation. The mechanisms involved remain to be established. 290 
Increased expression of contractile proteins has been observed in biopsies from asthmatic 291 
donors compared to non-asthmatic donors and may contribute to AHR (48). Expression of smooth 292 
muscle specific genes has been shown to be dependent on the binding of serum response factor 293 
(SRF) to the CArG [CC(A/T)6GG] box found in the promotors of contractile proteins, including sm-294 
MHC and calponin (44). In line with an increased SRF binding, we found that expression of sm-MHC 295 
and calponin mRNA was increased in laminin α5 deficient cells. Increased expression of contractile 296 
proteins, including sm-MHC and calponin mRNA, has also been shown in tracheal smooth muscle 297 
tissue treated with antisense oligodeoxynucleotides directed against Integrin-linked kinase (ILK) (50). 298 
Reduced expression of ILK in these tissues resulted in an increased binding of SRF to the promotors 299 
of sm-MHC and calponin providing a potential link between integrins and contractile protein 300 
expression. Silencing of ILK resulted in an increased protein expression of sm-MHC, but not of 301 
calponin (50). In cultured ASM cells expression of sm-MHC is very low (17), therefore we were 302 
unable to quantify the effect laminin α5 knock-down on sm-MHC protein expression. Expression of 303 




sm-MHC could thus be increased. Future studies using alternative culture systems should address 304 
whether sm-MHC protein expression requires laminin α5. Conversely, increased expression of 305 
calponin mRNA did not result in an increased protein expression, which is also in line with previous 306 
studies (50). Reasons for this discrepancy between mRNA and protein expression may be due to a 307 
number of factors, including differences in protein degradation, posttranslational mechanisms which 308 
regulate protein expression, differential expression of co-factors and/or amount of protein synthesis 309 
relative to basal protein expression (50).  310 
Inflammation is a characteristic feature of asthma and contributes to both acute and 311 
persistent AHR (24). Acute AHR is transient and associated with episodic airway inflammation, 312 
whereas persistent AHR is associated with airway remodeling in response to recurrent airway 313 
inflammation (24). During extravasation, leukocytes cross the endothelial layer and penetrate the 314 
underlying BM. This step appears to be rate-limiting as leukocytes accumulate at the BM (38). 315 
Penetration of the BM depends on its composition (20, 33, 49). Laminin α4 is ubiquitously localized 316 
in the endothelial BMs, while laminin α5 distribution is patchy (49). Extravasation of T-lymphocytes, 317 
neutrophils and monocytes occurs predominantly at sites expressing no or low laminin α5 (20, 43, 318 
49), indicating that laminin α5 may restrict, whereas laminin α4 may promote extravasation. In the 319 
current study, we found that expression of endothelial laminin α4 is increased in asthmatic patients, 320 
which could promote inflammatory cell infiltration (19). In line, inhibition of laminin α4 using 321 
function-blocking antibodies prevented allergen-induced increases in eosinophil infiltration, both in 322 
the acute and chronic mouse model. In contrast to our expectations, no increase in inflammatory 323 
cell migration was observed in laminin α5-blocking antibody treated mice.  324 
The relative expression of laminin α4 in relation to laminin α5 has been shown to regulate 325 
α6β1 integrin-dependent T cell migration across laminin α4 matrices (49). Migration was maximal in 326 
the absence of laminin α5 and decreased with increasing proportions of laminin α5, indicating that 327 
not only the absolute expression of laminin α4, but also the balance between laminin α4 and laminin 328 
α5 is important in these processes (49). In our studies, knock-down of laminin α4 resulted in an 329 




increased laminin α5 mRNA expression in ASM cells. These findings are in line with previous studies 330 
in laminin α4 knock-out mice showing an ubiquitous expression of laminin α5 along the vessels, 331 
whereas expression of this laminin was patchy and lower in wild-type littermates (49). Although an 332 
increased laminin α5 expression could contribute to the observed effects of the laminin α4 knock-333 
down in ASM cells, this is not very likely as we did not observe significant effects of laminin α5 334 
knock-down on proliferation or contractile protein in these cells. An effect of an altered laminin α4 335 
to laminin α5 (laminin α4/α5 ratio) could, which has previously been found to be relevant for 336 
lymphocyte migration across vascular laminins (49), on ASM function cannot be ruled out. In line, in 337 
our biopsy studies a laminin α4/α5 ratio in the ASM bundle greater than 1 was associated with 338 
clinical characteristics in asthma.  339 
Increased laminin α4 expression in ASM was associated with increased numbers of 340 
eosinophils in asthmatic patients. Although regulation of laminin expression is poorly described, 341 
endothelial expression of laminin α4 has been shown to be strongly upregulated by pro-342 
inflammatory stimuli, such as lipopolysaccharide, interleukin-1β and tumor necrosis factor-α (33), 343 
which may indicate that the increased ASM laminin α4 expression is the result of inflammation.  344 
Recently, a number of studies have shown that components of the laminin-integrin signaling 345 
axis may contribute to ASM abnormalities in asthma. Expression of CD151, a 4-transmembrane 346 
glycoprotein which associates with laminin-binding integrins, has been shown to be increased in the 347 
ASM of asthmatic patients (30). In these studies, CD151 was shown to associate with the laminin-348 
binding α7B integrin and was required for G protein-coupled receptor-induced calcium mobilization 349 
in human ASM cells and AHR in a mouse model of asthma. Similarly, expression of integrin α7 was 350 
shown to be increased in the ASM bundle of asthmatic patients (37). This integrin has previously 351 
been shown to be associated with a contractile ASM phenotype and knock-down of this integrin 352 
prevented the induction of a contractile phenotype (39). Moreover, this integrin was shown to be 353 
involved in ASM survival (41), suggesting that the laminin-integrin signaling axis may be involved in 354 
both increased ASM contractility as well as increased ASM mass, through reduced apoptosis. These 355 




effects have thus far been attributed to the laminin α2 chain, as induction of a contractile, 356 
hypoproliferative ASM phenotype was associated with increased expression of this laminin chain 357 
(15, 40). Moreover, allergen-induced AHR was not observed in laminin α2 deficient mice (41). These 358 
effects of laminin α2 in ASM cells are inhibited by the laminin β1 competing peptide Tyr-Ile-Gly-Ser-359 
Arg (YIGSR) (15, 40, 41). In contrast to expectations from these in vitro studies, in vivo treatment 360 
with YIGSR attenuated the allergen-induced increase in ASM mass and enhanced ASM contractile 361 
protein expression and - contractility, both in control and in allergen-challenged animals (11). In the 362 
current study, we show that in addition to laminin α2, laminin α4 also plays an important role in 363 
ASM abnormalities, providing a potential explanation for the contrasting observations with the 364 
YIGSR peptide in the in vivo model (11).  365 
In conclusion, our results suggest that laminin α4 is involved in airway remodeling and 366 
inflammation in asthma, which may contribute to lung function limitation and AHR. The role of 367 
laminin α5 in these processes is less apparent and requires further investigation. On the basis of 368 
these results, laminin α4 and/or its integrin ligand(s) may represent a novel target for the treatment 369 
of inflammation and airway remodeling in asthma. 370 
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Table 1  Clinical characteristics 530 
 Control subjects Asthmatic patients 
Number 20 32 
Gender (M/F) 11/9 12/20 
Age (years)†  43 (19-65) 52 (19-71) 
Current smoking, n (%) 9 (45) 6 (19)* 
Atopy, n (%) 5 (25) 24 (67)*** 
β-agonist use, n (%) 0 18 (56) 
ICS use, n (%) 0 15 (47) 
FEV1 (% pred)† 109 (83-132) 87 (34-134)*** 
FEV1/FVC (%)† 78 (71-88) 67 (40-86)*** 
Reversibility (%)† 2.7 (-7.4-8.2) 8.7 (1.3-38.4)*** 
PC20AMP (mg/ml)† >320 (231.1 to >320) 8.7 (0.01 to >320)*** 
†Data are presented as median (range). Atopy is defined as the ratio of the concentration of specific 531 
IgE’s in patient serum relative to the concentration of specific IgE's in control serum >1 (5). *P<0.05, 532 
***P˂0.001 versus control subjects.  533 




Figure legends 534 
Figure 1 Laminin α4 and α5 are expressed in human airways. Stainings were performed on 535 
tracheal sections were obtained from one lung transplantation donor. (A) Localization of pan-laminin 536 
(green) in the basement membranes of the endothelium (Endo), epithelium (Epi), submucosal glands 537 
(SG) and airway smooth muscle (ASM). (B) Localization of laminin α4 (green) in the basement 538 
membrane of the endothelium and airway smooth muscle. (C) Expression of laminin α5 (red) in the 539 
basement membrane of the epithelium, endothelium, submucosal glands and airway smooth 540 
muscle. Pictures were taken at a 400× magnification. Blue: nuclei. 541 
 542 
Figure 2 Laminin α4 is involved in the induction of a pro-fibrotic, pro-proliferative, and pro-543 
contractile ASM phenotype in vitro. (A) Laminin mRNA expression by human ASM cells. (B) Laminin 544 
α4 mRNA expression is reduced by lentiviral shRNA directed against this laminin. No effects were 545 
observed for lentiviral shRNA directed against laminin α5. (C) Laminin α5 mRNA expression is 546 
reduced by lentiviral shRNA directed against this laminin. Lentiviral shRNA directed against laminin 547 
α4 increased laminin α5 mRNA expression. (D) Cell number is reduced in laminin α4 deficient cells. 548 
(E) Regulation of sm-MHC, calponin, sm-α-actin and fibronectin mRNA expression in laminin α4 and 549 
α5 deficient cells. (F-H) Protein expression of sm-α-actin, calponin and fibronectin is reduced in 550 
laminin α4 deficient cells. Data represent means±SEM of 4-12 experiments. *P˂0.05, **P˂0.01, 551 
***P˂0.001 compared to scrambled shRNA transfected cells. 552 
 553 
Figure 3 Laminin α4 and α5 are involved in airway smooth muscle accumulation in vivo. (A) 554 
Experimental animal procedures. Female BALB/c were sensitized to ovalbumin (OVA) on Days 1, 14, 555 
and 21. For the acute protocol, mice were challenged with saline or 1% OVA aerosols for 20 minutes 556 
on days 28-30. On day 32, animals were exposed to saline or 5% OVA and sacrificed 6 hours 557 
thereafter. For the chronic protocol, animals were exposed to saline or 1% OVA aerosols twice 558 
weekly from days 26 to 48. Mice were sacrificed 24 hours after the last challenge. Laminin α4 or α5 559 




function-blocking antibodies or control IgG antibodies were administered on day 27 (acute protocol) 560 
or days 25 and 39 (chronic protocol). (B) Representative photographs of laminin α4 and α5 staining 561 
in mouse lung tissue after repeated ovalbumin challenge. Localization of laminin α4 (green) in the 562 
basement membrane (BM) of the alveoli (AV) and airway smooth muscle (ASM). Expression of 563 
laminin α5 (red) in the BM of the alveoli, epithelium (Epi) and ASM. Pictures were taken at 400× 564 
magnification. AW: airway, V: vessel. Blue: nuclei. (C) Treatment with laminin function-blocking 565 
antibodies prevented allergen-induced ASM accumulation in the chronic model. #P<0.05, ##P<0.01 566 
compared with IgG-treated, ovalbumin-challenged controls. Data represent means±SEM of 3-6 567 
animals.  568 
 569 
Figure 4 Basal airway eosinophil numbers and allergen-induced increases in eosinophils are 570 
inhibited by laminin α4 blocking antibodies. (A) Effects of laminin function-blocking antibodies on 571 
acute allergen-induced airway infiltration of eosinophils. (B) Effects of laminin function-blocking 572 
antibodies on chronic allergen-induced airway infiltration of eosinophils. *P<0.05 compared to with 573 
IgG-treated, saline-challenged controls. #P<0.05 compared with IgG-treated, ovalbumin-challenged 574 
controls. Data represent means±SEM of 3-6 animals. BM: basement membrane. 575 
 576 
Figure 5  Laminin α4 scoring is associated with clinical characteristics of asthmatic patients. 577 
(A,B) Representative photographs of staining for (A) laminin α4 and (B) laminin α5 in ASM, 578 
epithelium and endothelium in biopsy sections. (C,D) High (score 3-4) laminin α4 staining is 579 
associated with reduced lung function of asthmatic patients expressed as both (C) FEV1 %predicted 580 
and (D) FEV1/FVC %predicted. (E) High (score 3-4) laminin α4 staining is associated with increased 581 
airway reactivity of asthmatic patients to adenosine monophosphate (AMP). (F) High (score 3-4) 582 
laminin α4 staining is associated with increased numbers of EPX-positive eosinophils in the airway 583 
biopsies of asthmatic patients. Results from 20 control subjects and 31 asthmatic patients are shown 584 




in Figs C-F. **P˂0.01, ***P˂0.001. Examples of staining intensity scores 1-4 are shown in 585 
supplemental Figure S1. 586 
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